Recent Posts
-
AZURITY PHARMACEUTICALS, INC. ANNOUNCES AVAILABILITY OF
AZMIRO™ (testosterone cypionate) injection for intramuscular use, CIII -
AZURITY PHARMACEUTICALS, INC. ANNOUNCES FDA APPROVAL OF
DANZITEN™ (nilotinib) tablets, THE FIRST AND ONLY NILOTINIB WITH NO MEALTIME RESTRICTIONS -
AZURITY PHARMACEUTICALS, INC. ANNOUNCES FDA APPROVAL OF
NYMALIZE® (NIMODIPINE) ORAL SOLUTION 30 MG/5 ML PREFILLED ENFIT® SYRINGE -
AZURITY PHARMACEUTICALS, INC. ANNOUNCES FDA APPROVAL OF
MYHIBBIN™ (mycophenolate mofetil oral suspension) -
Azurity Pharmaceuticals, Inc. Issues Voluntary Nationwide Recall of
Zenzedi® (dextroamphetamine sulfate tablets, USP) 30 mg Due to a Mislabeled Package During Manufacturing
Recent Comments